Should I open or buy a Profile by Sanford franchise in 2027?

Open new versus buy existing: the two paths compared

The decision framing most prospective owners get wrong is treating "should I get into Profile by Sanford" as one question. It is two, and they have opposite risk profiles in a category being restructured by pharmacology.

Opening a new studio means signing a fresh franchise agreement, paying the franchise fee around $40,000, and carrying a total Item 7 investment of roughly $200,000 to $400,000 per the 2026 FDD. You pick the territory (from what's left), you pick the site, you hire your own coaches, and you own the culture from day one. You also own eighteen months of ramp with no revenue history to borrow against. In a stable category, that ramp is a known cost you underwrite and absorb. In a category where the underlying consumer behavior is actively shifting — and weight loss in 2027 is exactly that category — you are underwriting a ramp into a demand curve nobody can draw with confidence. Your pre-opening pro forma assumes a client acquisition cost and a membership retention rate derived from the pre-GLP-1 era, and there is no honest way to know whether those numbers still hold in your ZIP code.

Buying an existing studio means paying a resale price that has historically landed between $80,000 and $250,000 for a mature, profitable location, typically at 1.5 to 2.5 times seller's discretionary earnings, plus a transfer fee often in the $10,000 to $15,000 range. You inherit a real client list, real coach payroll, a real lease, and — critically — a real answer to the question that matters most: what percentage of this studio's members are already using GLP-1 medications, and did the studio keep them or lose them? That's not a projection. That's a spreadsheet you can read.

The asymmetry is stark. A new build asks you to spend two to four times more money to buy a hypothesis. A resale asks you to spend less money to buy a measured reality — including, potentially, a bad reality, which you can then walk away from before wiring funds. Diligence on a resale is *falsifiable*. Diligence on a greenfield build is mostly vibes and franchisor decks.

The counterargument for building new is real but narrow. If every available resale in your region is a distressed studio whose owner is exiting precisely because they never adapted, you'd be buying someone else's structural failure at a discount that isn't deep enough. And if you're in a market where Sanford Health carries genuine brand weight — the Dakotas, Minnesota, Iowa, parts of the upper Midwest — but has no studio yet, the territory itself may be worth more than the ramp costs. Brand recognition in a health system's home footprint is not a small thing; patients trust a name they associate with actual clinicians.

There is also a third path most people don't consider: buy the smallest viable existing unit, then open a second location in an adjacent territory once you've operated for eighteen months. You learn the model on someone else's proven client base, then deploy capital into a build with real operating knowledge instead of franchisor projections. Multi-unit franchisees in most systems outperform single-unit owners on margin, and the reason is boring — they amortize a general manager, shared marketing spend, and back-office admin across two revenue lines. If you can only afford one path in 2027, buy. If you have a five-year horizon, buy first and build second.

How to decide between them

Run the decision in a fixed order, because the disqualifying questions are cheap and the expensive questions are only worth asking if you clear the cheap ones.

The first gate is the brand's GLP-1 posture, and it disqualifies both paths equally. Profile's model is one-on-one coaching, a structured nutrition plan, and branded meal products and supplements sold on a membership basis. That model was built for a world where the binding constraint on weight loss was behavioral adherence. GLP-1 receptor agonists — semaglutide and tirzepatide, sold as Ozempic, Wegovy, Zepbound and Mounjaro — substantially relax that constraint for many patients by suppressing appetite pharmacologically. A coaching program positioned as a *substitute* for that is selling a harder path to the same destination. A coaching program positioned as a *complement* — muscle preservation through adequate protein and resistance training, side-effect management, nutritional adequacy at drastically reduced caloric intake, and maintenance after discontinuation — is selling something the drugs genuinely do not provide. Weight regain after stopping GLP-1 therapy is well documented in the clinical literature, and that is the coaching industry's strongest structural argument for its own continued relevance.

So: does the franchisor have documented protocols, franchisee training, and marketing collateral for coaching medicated clients? Not a paragraph on a website. Actual operating material. If the answer is no, stop. Neither path works.

The second gate is market fit, which is measurable before you spend anything meaningful. You want household income at or above roughly $75,000, adult obesity prevalence above the national average, and — this is the one people skip — some evidence of local employer wellness spending. Corporate contracts smooth the seasonality that wrecks weight-loss studios. January is enormous; August is a graveyard. A studio with three employer accounts has a floor. A studio with only walk-in retail members rides a sine wave, and that sine wave is what breaks undercapitalized owners in year two.

The third gate is capital, and it's where the two paths genuinely diverge. New build: $200,000 to $400,000 all in, with $80,000 to $150,000 of that needing to be liquid, plus working capital sufficient to fund six to nine months of negative cash flow — I'd argue for nine, not the three-to-six that pro formas usually assume, because ramp in a disrupted category runs long. Resale: purchase price plus transfer fee plus a working capital cushion, and if the studio is genuinely profitable you're funding a much shorter gap. SBA 7(a) lenders will generally look more favorably on a resale with two to three years of tax returns than on a startup projection in a category they've read unflattering headlines about — and lender skepticism is itself a useful signal about the category.

The order matters more than any individual answer. People run this backwards — they find a site they love, fall for it, and then rationalize the GLP-1 question. Site selection is the last decision, not the first.

Concrete numbers behind each option

Here is what each path actually costs and returns, using the 2026 FDD figures and the reported operating ranges. Treat all of it as a framework to test against the franchisor's own Item 19 and the seller's tax returns, not as a substitute for either.

Opening new. The franchise fee sits around $40,000. Buildout and leasehold improvements on a 1,200 to 2,000 square foot studio run roughly $90,000 to $220,000 depending on the shell condition and your market's construction costs — a second-generation retail space with usable plumbing and HVAC can land at the bottom of that range, while a raw white box in a high-cost metro pushes the top. Equipment and fixtures for the coaching rooms and the retail product wall run $30,000 to $75,000. Brand-prescribed signage and decor: $12,000 to $40,000. Initial inventory of meal products: $20,000 to $55,000. Pre-opening marketing to build a membership pipeline before you unlock the door: $20,000 to $50,000. Owner and coach training plus travel: $8,000 to $22,000. Working capital: $30,000 to $80,000 in the FDD, which I'd treat as a floor rather than a plan.

Total: roughly $200,000 to $400,000. Ongoing, a royalty near 5% of gross and a marketing fee around 2%.

Note the smaller-footprint option. Post-pandemic hybrid coaching — in-person plus virtual sessions — has let some locations operate below the traditional square footage, and where the franchisor approves a reduced footprint the initial investment can drop meaningfully, on the order of 15% to 25%. The trade-off is real capacity: fewer coaching rooms means fewer simultaneous sessions means a lower revenue ceiling. That math favors reduced footprint in high-rent metros where rent is the binding constraint, and favors full footprint in cheaper markets where you want the throughput.

Buying existing. Resales in this system have reportedly transacted between $80,000 and $250,000 for mature, profitable studios, at roughly 1.5 to 2.5 times owner's discretionary profit. Add the transfer fee, typically $10,000 to $15,000. Add whatever deferred maintenance and equipment refresh the seller has been avoiding — walk the space with a contractor, not just the seller. Add working capital, though far less than a startup needs if the studio is genuinely cash-positive on day one.

You may also inherit a lease with unfavorable remaining terms, a franchise agreement with only three years left before a renewal decision, and coaches whose loyalty is to the departing owner. Price all three. The franchise agreement term is the one people miss — a ten-year agreement with two years remaining is a materially different asset than one with eight, because renewal typically means a new fee and current-form terms, which may be less favorable than the ones the seller signed.

The revenue picture, either way. Mature studios reportedly gross $400,000 to $1,000,000 annually across coaching memberships and branded product sales, with owners clearing roughly $70,000 to $200,000. Satellite or express formats in smaller towns — populations under about 30,000 — generate materially less, in the $200,000 to $400,000 gross range, which can still work if your rent and payroll scale down proportionally but leaves far less margin for error.

Work a mid-case $700,000 studio. Coach labor is the largest line at roughly a third of revenue — this is a people business and you cannot automate the coaching without becoming an app, at which point you are competing with actual apps at actual app prices. Cost of the meal products and supplements runs another fifth or so. Rent plus the 5% royalty plus the 2% marketing fee take a meaningful bite. Marketing beyond the brand fund and general admin take another. What's left is owner earnings in the low six figures — real money for an owner-operator, thin for an absentee investor paying a general manager out of it.

The absentee question deserves emphasis because it quietly kills more franchise investments than bad unit economics do. At these revenue levels, a competent general manager's salary and payroll burden consume a large share of owner earnings. This is an owner-operator business at one unit. It becomes an investor business at three or four units, when a shared district manager amortizes across enough revenue to leave something behind. If you're buying one studio expecting passive income, the numbers will not cooperate.

Territory economics. Territories reportedly run roughly 50,000 to 100,000 residents. Do the arithmetic on penetration: a studio grossing $700,000 on memberships plus product across a 75,000-person territory is serving a small single-digit-percentage slice of adults, probably well under one percent. That's a comfortingly low bar — you don't need to convert a town — but it also means your growth ceiling is set by marketing reach and referral velocity, not by market exhaustion. You will never "run out" of prospects. You will run out of efficient ways to reach them, which is a different and more solvable problem.

Also weigh territory availability geographically. Much of the Midwest, where Sanford Health's name means something to consumers, has been developed. Territories in the Southeast, Southwest and West Coast may be more available but come with higher buildout costs and a brand nobody's heard of — you're paying a franchise fee for a system, not for recognition, which changes the value calculation considerably.

Adjacent plays worth pricing before you commit

Do not evaluate this franchise in isolation. The right comparison set is every way to deploy $200,000 to $400,000 into the same consumer demand.

Medical weight-loss clinics — the model that prescribes rather than complements. Systems like Medi-Weightloss operate physician-supervised programs and are positioned directly with the pharmacological trend rather than adjacent to it. Higher regulatory complexity, a required medical director relationship, and different licensure by state, but you're selling what the market is currently buying. If the GLP-1 shift is durable — and the clinical evidence on efficacy suggests it is — this category has the tailwind. The counter-risk is compression: as more prescribers enter, including telehealth platforms operating at national scale with no real estate cost, price competition on the prescription itself gets brutal. Coaching may end up being the defensible margin precisely because it can't be delivered by a fifteen-minute async video visit.

Broader wellness formats — recovery, IV therapy, cryotherapy, body composition. Wider revenue base, less exposure to any single modality's disruption, generally higher buildout cost. The diversification is real but so is the operational complexity of running four service lines instead of one.

Med-spa and aesthetics — adjacent demographics, often overlapping clientele, frequently adding weight-loss injectables to existing service menus. Higher regulatory burden and higher capital requirements, but strong per-visit economics.

Fitness with a nutrition attachment — the inverse bet. If GLP-1 users lose lean mass alongside fat, resistance training becomes clinically more important, not less. Strength-focused studio formats may benefit from the same trend that pressures pure coaching.

Independent coaching, no franchise. You keep the 5% royalty and the 2% marketing fee — seven points of gross, which on a $700,000 studio is roughly $49,000 a year, comparable to what many owners net after everything else. You give up the playbook, the training system, the supply chain for branded products, and the credibility of a health-system-affiliated name. For an experienced operator with an existing local reputation, that trade can favor going independent. For a first-time owner, the playbook is worth paying for — franchising's real product is a reduced failure rate, not a higher ceiling.

The honest framing: Profile by Sanford's differentiation is science-backed credibility from Sanford Health plus recurring membership revenue. Both are genuine. Neither is immune to a category-level demand shift. Price the alternatives before you sign anything.

Implementation and sequencing, whichever path you pick

Sequence the work so the cheap disqualifiers come first. Every step below is ordered to kill the deal as early and as inexpensively as possible.

Weeks 1–3: documents. Get the current FDD and read Items 5, 6, 7, 19, 20 and 21 in that order. Item 20 is the one that talks — it lists outlet counts by year, including terminations, non-renewals, transfers and ceased operations. A system with rising terminations in 2024–2026 is telling you something about the GLP-1 transition that no franchise development rep will. Item 19 tells you what financial performance representation the franchisor is willing to make and, just as importantly, what subset of outlets it's drawn from. If Item 19 reports only top-quartile studios, that's a choice worth asking about. Have a franchise attorney read it too — a few thousand dollars against a several-hundred-thousand-dollar commitment is not a close call.

Weeks 3–7: franchisee validation. Call every franchisee you can reach from the Item 20 list, not the referral list the franchisor hands you. Target ten or more conversations, including at least two who left the system. Ask precisely: What share of your clients are on GLP-1 medications now versus two years ago? Did they stay or churn? What did corporate give you to handle them — actual training or a memo? What's your membership retention at six and twelve months? What did you actually net last year, not gross? Would you sign again today? That last question, asked plainly and then met with silence, produces the most honest data you will get in this entire process.

Weeks 5–9: market validation. Pull demographics, obesity prevalence, and competitor density. Physically visit competitors — the medical clinics, the independent coaches, the gyms with nutrition programs. Ask what's changed for them. Talk to two or three local employers about wellness benefit spending. If nobody in your market is buying weight-loss services from anyone, the problem is the market, not the brand.

Weeks 8–12: path-specific diligence.

*If buying:* three years of tax returns, not P&Ls. Reconcile deposits against reported revenue. Get the client list with tenure and payment history and calculate real churn yourself. Get the lease with all amendments. Get the remaining franchise agreement term and the renewal terms. Interview the coaches privately about whether they intend to stay. Walk the space with a contractor. Structure a portion of the price as a seller note or an earnout tied to twelve-month client retention — if the seller refuses any contingent consideration, ask yourself why they don't believe their own retention numbers.

*If opening:* site selection with a broker who works retail in your market, not the franchisor's preferred vendor alone. Negotiate lease term, tenant improvement allowance, and a co-tenancy clause. Line up SBA financing early. Decide footprint deliberately — reduced footprint in expensive markets, full in cheap ones.

Weeks 12–20: build and staff. Permits will take longer than anyone tells you; municipal plan review is the single most common source of opening delay in retail franchising. Hire your lead coach early enough to train them properly. From signing to opening typically runs six to twelve months, and treating that as a floor rather than a target avoids the cash-flow squeeze that comes from committing to rent before you can bill members.

Weeks 18–24: pre-sell. This is where new builds are won or lost. Sell founding memberships before you open. A studio that opens with eighty committed members has a fundamentally different first year than one that opens empty and hopes. Position explicitly around the complement thesis: nutrition and lifestyle support for people on medication, muscle preservation, side-effect management, and maintenance after they stop. That's the message that survives the category shift.

After opening, track one metric religiously that most owners don't: the share of your active members who are on GLP-1 medications. That number tells you whether your positioning is working. If it's growing and those members retain as well as your unmedicated ones, the complement thesis is proven in your market and you should lean harder into it. If medicated members churn faster, your coaching product isn't delivering something they can't get from the prescription alone, and you need to fix the product before you spend another dollar on marketing.

Exit planning starts at entry. Typical hold periods in this system run five to eight years, so build projections on a seven-to-ten-year horizon and understand the renewal decision inside the ten-year agreement term. Your buyer in year seven will ask exactly the questions you're asking now. Build the studio whose answers are good.

Related questions

Is a resale always safer than a new build here?

No. A resale from an owner exiting because they never adapted to GLP-1s is a structural failure sold at an insufficient discount. The resale advantage is *measurable retention data* — if that data is bad, the lower price doesn't compensate. Walk.

How much liquid capital do lenders want to see?

For a new build in the $200,000 to $400,000 range, expect to need roughly $80,000 to $150,000 liquid, plus acceptable credit and often collateral. SBA lenders generally view resales with real tax returns more favorably than startup projections in a disrupted category.

Can this be run absentee?

Realistically, no, at one unit. A general manager's fully-loaded cost consumes most of the low-six-figure owner earnings. It becomes an investor-scale business at three or four units where district-level management amortizes across enough revenue.

What single question predicts franchisee satisfaction best?

"Would you sign this agreement again today, knowing what you know?" Ask it, then stop talking. The pause before the answer carries more information than the answer.

Does Sanford Health backing actually matter to customers?

In the upper Midwest, meaningfully yes — consumers associate the name with clinicians. Outside that footprint, you're buying an operating system rather than brand recognition, which changes what the franchise fee is actually purchasing.

FAQ

What does it cost to open a Profile by Sanford franchise?

The 2026 FDD lists a franchise fee around $40,000 and a total Item 7 investment of roughly $200,000 to $400,000, covering buildout, equipment, signage, initial meal-product inventory, pre-opening marketing, training and working capital. Ongoing obligations include a royalty near 5% of gross and a marketing fee around 2%. Reduced-footprint locations, where approved, can lower the initial investment by roughly 15% to 25% at the cost of in-person capacity.

What do studios actually earn?

Mature studios reportedly gross $400,000 to $1,000,000 annually across coaching memberships and branded product sales, with owners clearing roughly $70,000 to $200,000. Satellite formats in markets under about 30,000 people generate materially less, in the $200,000 to $400,000 range. Verify every figure against the franchisor's Item 19 and, on a resale, against three years of the seller's tax returns rather than P&Ls.

How do GLP-1 drugs change the business case?

They relax the behavioral-adherence constraint that coaching programs were built to solve. Positioned as a substitute for medication, coaching is a harder sell. Positioned as a complement — muscle preservation, side-effect management, nutritional adequacy at low caloric intake, and maintenance after discontinuation, since regain after stopping is well documented — coaching addresses needs the drugs don't. Validate that the franchisor has real protocols and training, not marketing language.

Is buying an existing studio actually cheaper?

Usually. Resales have reportedly transacted at $80,000 to $250,000 for mature profitable studios, roughly 1.5 to 2.5 times owner's discretionary profit, plus a transfer fee often around $10,000 to $15,000. Beyond price, you're buying measurable retention data instead of a projection. Price the remaining lease term, the remaining franchise agreement term, deferred maintenance, and coach retention risk into the offer.

What should I look for in Item 20 of the FDD?

Outlet counts by year including openings, terminations, non-renewals, transfers and ceased operations. A rising termination or transfer rate across 2024 to 2026 signals how the system weathered the category shift more honestly than any franchise development conversation will. Item 20 also provides the contact list for current and former franchisees — call from that list, not the curated referral list.

How long from signing to opening?

Typically six to twelve months, driven by site selection, municipal permitting and buildout. Treat twelve as the planning assumption rather than six, since permitting delays are the most common cause of overrun and rent obligations often begin before you can bill a single member. Use the extra time to pre-sell founding memberships so you open with committed revenue.

Sources

• https://www.ftc.gov/business-guidance/resources/franchise-rule-compliance-guide
• https://www.sba.gov/funding-programs/loans/7a-loans
• https://www.nih.gov/news-events/nih-research-matters
• https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers
• https://www.cdc.gov/obesity/data/adult.html
• https://www.entrepreneur.com/franchises
• https://www.franchise.org/
• https://www.census.gov/topics/income-poverty/income.html
• https://www.bls.gov/oes/current/oes119111.htm
• https://www.nih.gov/news-events/news-releases

Related on PULSE

• [How long does it take to open a franchise and break even in 2027?](/knowledge/fr1104)
• [Should I open or buy a Tommy Gun's Original Barbershop franchise in 2027?](/knowledge/fr1095)
• [Should I open or buy a Painting with a Twist franchise in 2027?](/knowledge/fr1058)
• [What should I look for in Item 19 of a Franchise Disclosure Document?](/knowledge/fr1104)
• [Is buying an existing franchise resale safer than opening a new unit?](/knowledge/fr1058)